BACKGROUND: The epidermal growth factor receptor (EGFR) mediates regulatory signals in the normal prostate, but the functional importance of this is unclear. METHODS: Adult male rats were castrated, or castrated + treated with gefitinib (Iressa, ZD1839), an EGFR tyrosine kinase inhibitor, for 3 days. Seven-day castrated rats were treated with testosterone, or testosterone + gefitinib, for 3 days. RESULTS: Both castration alone and testosterone treatment in castrated animals increased the mRNA and protein levels of EGFR and phospho-EGFR in the ventral prostate. Inhibition of EGFR during castration and during testosterone-stimulated prostate growth resulted in a decrease in total epithelial weight, epithelial cell proliferation, endothelial cell proliferation, and increased epithelial cell apoptosis. CONCLUSIONS: This study suggests that increased EGFR signaling during castration mediates stimulatory effects balancing castration-induced prostate regression, and that EGFR signaling is a necessary component in testosterone-stimulated prostate growth. (c) 2007 Wiley-Liss, Inc.
BACKGROUND: The epidermal growth factor receptor (EGFR) mediates regulatory signals in the normal prostate, but the functional importance of this is unclear. METHODS: Adult male rats were castrated, or castrated + treated with gefitinib (Iressa, ZD1839), an EGFR tyrosine kinase inhibitor, for 3 days. Seven-day castrated rats were treated with testosterone, or testosterone + gefitinib, for 3 days. RESULTS: Both castration alone and testosterone treatment in castrated animals increased the mRNA and protein levels of EGFR and phospho-EGFR in the ventral prostate. Inhibition of EGFR during castration and during testosterone-stimulated prostate growth resulted in a decrease in total epithelial weight, epithelial cell proliferation, endothelial cell proliferation, and increased epithelial cell apoptosis. CONCLUSIONS: This study suggests that increased EGFR signaling during castration mediates stimulatory effects balancing castration-induced prostate regression, and that EGFR signaling is a necessary component in testosterone-stimulated prostate growth. (c) 2007 Wiley-Liss, Inc.
Authors: L Rinnab; A Hessenauer; S V Schütz; E Schmid; R Küfer; F Finter; R E Hautmann; K D Spindler; M V Cronauer Journal: Urologe A Date: 2008-03 Impact factor: 0.639
Authors: Peter Hammarsten; Mariateresa Cipriano; Andreas Josefsson; Pär Stattin; Lars Egevad; Torvald Granfors; Christopher J Fowler Journal: PLoS One Date: 2012-10-25 Impact factor: 3.240
Authors: Peter Hammarsten; Johanna Winther; Stina H Rudolfsson; Jenny Häggström; Amar Karalija; Lars Egevad; Torvald Granfors; Christopher J Fowler Journal: PLoS One Date: 2014-09-12 Impact factor: 3.240
Authors: Marie Lundholm; Christina Hägglöf; Maria L Wikberg; Pär Stattin; Lars Egevad; Anders Bergh; Pernilla Wikström; Richard Palmqvist; Sofia Edin Journal: Sci Rep Date: 2015-10-27 Impact factor: 4.379